Kiropraktik Danmark ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.1% 9.7% 16.6% 9.0% 5.0%  
Credit score (0-100)  44 25 9 27 43  
Credit rating  BBB BB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  93.5 82.6 45.6 60.4 105  
EBITDA  93.5 82.6 45.6 60.4 105  
EBIT  74.4 63.5 45.6 60.4 88.0  
Pre-tax profit (PTP)  114.0 103.7 90.0 106.0 108.3  
Net earnings  88.9 80.8 70.2 82.7 83.9  
Pre-tax profit without non-rec. items  114 104 90.0 106 108  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  19.1 0.0 0.0 0.0 95.6  
Shareholders equity total  910 991 1,061 1,144 527  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 30.0  
Balance sheet total (assets)  1,001 1,107 1,138 1,222 600  

Net Debt  -23.7 -8.0 -58.0 -57.1 -25.7  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  93.5 82.6 45.6 60.4 105  
Gross profit growth  -56.5% -11.6% -44.8% 32.5% 73.6%  
Employees  2 1 0 0 0  
Employee growth %  -50.0% -50.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,001 1,107 1,138 1,222 600  
Balance sheet change%  4.8% 10.6% 2.8% 7.4% -50.9%  
Added value  93.5 82.6 45.6 60.4 104.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -38 -38 0 0 79  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  79.6% 76.9% 100.0% 100.0% 83.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  11.7% 9.9% 8.0% 9.0% 11.9%  
ROI %  13.2% 11.0% 8.8% 9.6% 12.8%  
ROE %  10.3% 8.5% 6.8% 7.5% 10.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  95.2% 92.8% 97.2% 95.1% 87.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -25.3% -9.7% -127.1% -94.5% -24.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 5.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 2.9%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  21.3 14.1 36.6 20.8 7.2  
Current Ratio  10.8 9.5 14.7 15.6 7.2  
Cash and cash equivalent  23.7 8.0 58.0 57.1 55.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  890.7 990.6 1,060.8 1,143.5 434.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  47 83 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  47 83 0 0 0  
EBIT / employee  37 64 0 0 0  
Net earnings / employee  44 81 0 0 0